224 related articles for article (PubMed ID: 33124666)
1. Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
Ware JM; O'Connell EM; Brown T; Wetzler L; Talaat KR; Nutman TB; Nash TE
Clin Infect Dis; 2021 Oct; 73(7):e2457-e2562. PubMed ID: 33124666
[TBL] [Abstract][Full Text] [Related]
2. Interventions for American cutaneous and mucocutaneous leishmaniasis.
Pinart M; Rueda JR; Romero GA; Pinzón-Flórez CE; Osorio-Arango K; Silveira Maia-Elkhoury AN; Reveiz L; Elias VM; Tweed JA
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD004834. PubMed ID: 32853410
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
Kämink S; Masih B; Ali N; Ullah A; Khan SJ; Ashraf S; Pylypenko T; Grobusch MP; Fernhout J; den Boer M; Ritmeijer K
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008988. PubMed ID: 33507944
[TBL] [Abstract][Full Text] [Related]
4. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
Machado PR; Ampuero J; Guimarães LH; Villasboas L; Rocha AT; Schriefer A; Sousa RS; Talhari A; Penna G; Carvalho EM
PLoS Negl Trop Dis; 2010 Dec; 4(12):e912. PubMed ID: 21200420
[TBL] [Abstract][Full Text] [Related]
5. Miltefosine for new world cutaneous leishmaniasis.
Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
[TBL] [Abstract][Full Text] [Related]
6. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.
Rubiano LC; Miranda MC; Muvdi Arenas S; Montero LM; Rodríguez-Barraquer I; Garcerant D; Prager M; Osorio L; Rojas MX; Pérez M; Nicholls RS; Gore Saravia N
J Infect Dis; 2012 Feb; 205(4):684-92. PubMed ID: 22238470
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
Ollech A; Solomon M; Horev A; Reiss-Huss S; Ben-Amitai D; Zvulunov A; Friedland R; Atar-Snir V; Pessach-Molcho V; Barzilai A; Greenberger S
Acta Derm Venereol; 2020 Nov; 100(18):adv00322. PubMed ID: 33205828
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous Leishmaniasis Treated with Miltefosine: A Case Series of 10 Paediatric Patients.
Ollech A; Solomon M; Horev A; Reiss-Huss S; Ben-Amitai D; Zvulunov A; Friedland R; Atar-Snir V; Molho-Pessach V; Barzilai A; Greenberger S
Acta Derm Venereol; 2020 Oct; 100(18):adv00322. PubMed ID: 33074340
[TBL] [Abstract][Full Text] [Related]
9. Treatment of New World cutaneous leishmaniasis with miltefosine.
Soto J; Berman J
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S34-40. PubMed ID: 16930649
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous leishmaniasis in Switzerland: first experience with species-specific treatment.
Mosimann V; Neumayr A; Hatz C; Blum JA
Infection; 2013 Dec; 41(6):1177-82. PubMed ID: 23835701
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.
Vélez I; López L; Sánchez X; Mestra L; Rojas C; Rodríguez E
Am J Trop Med Hyg; 2010 Aug; 83(2):351-6. PubMed ID: 20682881
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
[TBL] [Abstract][Full Text] [Related]
13. Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
van Henten S; Tesfaye AB; Abdela SG; Tilahun F; Fikre H; Buyze J; Kassa M; Cnops L; Pareyn M; Mohammed R; Vogt F; Diro E; van Griensven J
PLoS Negl Trop Dis; 2021 May; 15(5):e0009460. PubMed ID: 34048461
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of the efficacy and safety of oral treatments with oleylphosphocholine (OlPC) and miltefosine in a mouse model of L. major cutaneous leishmaniasis.
Fortin A; Caridha DP; Leed S; Ngundam F; Sena J; Bosschaerts T; Parriott S; Hickman MR; Hudson TH; Grogl M
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3144. PubMed ID: 25210745
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil.
Chrusciak-Talhari A; Dietze R; Chrusciak Talhari C; da Silva RM; Gadelha Yamashita EP; de Oliveira Penna G; Lima Machado PR; Talhari S
Am J Trop Med Hyg; 2011 Feb; 84(2):255-60. PubMed ID: 21292895
[TBL] [Abstract][Full Text] [Related]
16. A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
Machado PRL; Prates FVO; Boaventura V; Lago T; Guimarães LH; Schriefer A; Corte TWF; Penna G; Barral A; Barral-Netto M; Carvalho EM
Clin Infect Dis; 2021 Oct; 73(7):e2465-e2469. PubMed ID: 32894278
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study between oral miltefosine and parenteral N-metil glucamine antimoniate for the treatment of experimental leishmaniasis caused Leishmania (Leishmania) amazonensis].
Costa Filho AV; Lucas IC; Sampaio RN
Rev Soc Bras Med Trop; 2008; 41(4):424-7. PubMed ID: 18853022
[TBL] [Abstract][Full Text] [Related]
19. [Oral miltefosine to treat leishmaniasis].
Soto J; Soto P
Biomedica; 2006 Oct; 26 Suppl 1():207-17. PubMed ID: 17361856
[TBL] [Abstract][Full Text] [Related]
20. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
